Enrolling Adult Women in a Testosterone Antidepressant Augmentation Clinical Trial for Major Depressive Disorder
Butler Hospital's Mood Disorders Research Program (MDRP) is currently enrolling women with major depressive disorder, ages 21-65, in a new research clinical trial. The study investigates the use of low-dose testosterone cream (applied to skin daily as an "add-on" treatment) when a woman's depression medications have not produced full relief from symptoms.
- Study participants will be randomly assigned to receive an active or placebo cream, while continuing on a stable dose of a their primary antidepressants.
- The study involves 6 visits to the MDRP research clinic on the Butler Hospital campus over an 8-week period. Limited transportation support is provided.
Adult women with major depressive disorder, ages 21-65.
If you are interested in learning more about the Testosterone Antidepressant Augmentation research study, please call (401) 455-6537 or fill out the following form:
Please provide your name, telephone number, and a good time to reach you in the boxes below. Please do not include any other information. When you are done, press submit. A member of the research team will contact you soon.